[1] MORTON A,LAURIE J.The biochemical diagnosis of intrahepatic cholestasis of pregnancy[J].Obstet Med,2019,12(2):76-78.
[2] 乐杰.妇产科学[M].第8版.北京:人民卫生出版社,2013:73-74.
[3] KULHAN M,KULHAN N G,NAYKI U,et al.Intrahepatic cholestasis of pregnancy and fetal outcomes[J].Arch Med Sci Civil Dis,2017,2(5):85-86.
[4] CARIELLO M,PIGLIONICA M,GADALETA R M,et al.The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism[J].Handb Exp Pharmacol,2019,256(21):73-93.
[5] SHI S Y,LU Y W,RICHARDSON J,et al.A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling[J].Sci Rep,2018,8(1):11045.
[6] 中华医学会妇产科学分会产科学组.妊娠期肝内胆汁淤积症诊疗指南(2015) [J].临床肝胆病杂志,2015,31 (10):1575-1578.
[7] 陶国伟,刘韶平,郝春燕.孕晚期超声监测胎盘成熟度分级与病理改变、妊娠结局的关系[J].中国超声医学杂志,2005,21(7):531-533.
[8] 蔡林燕.妊娠期肝内胆汁淤积症总胆汁酸、雌三醇与新生儿Apgar评分的关系[J].中国妇幼保健,2016,31(5):32-34.
[9] 钱燕,钱佩兰,郭丽云,等.妊娠期肝内胆汁淤积症血清胆汁酸与肝功能检测的临床意义[J].中国实用医药,2012,7(11):22-23.
[10] BROUWERS L.Intrahepatic cholestasis of pregnancy:maternal and fetal outcomes associated with elevated bile acid levels[J].Am J Obstet Gynecol,2015,212(1):100.
[11] OVADIA C.Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers:results of aggregate and individual patient data meta-analyses[J].Lancet,2019,393(10174):899-909.
[12] 陈剑青.低出生体重儿发生的影响因素及综合干预后的效果研究[J].中国妇幼保健,2017,32(8):1687-1689.
[13] GOIDMAN-WOHL D,YAGEL S.United we stand not dividing:the syncytiotrophoblast and cell senescence[J].Placenta,2014,35(6):341-344.
[14] ORNITZ D M,ITOH N.The fibroblast growth factor signaling pathway[J].Wiley Interdiscip Rev Dev Biol,2015,4(11):215-266.
[15] KLIEWER S A,MANGELSDORF D J.Bile acids as hormones:the FXR-FGF15/19 pathway[J].Dig Dis,2015,33(33):327-331.
[16] 马振增,陆伦根.FXR-FGF-19肠肝轴:一种新的肝属性[J].中国肝脏病学,2016,21(4):304-306.
[17] KELLY C,PERICLEOUS M.Pregnancy-associated liver disease:a curriculum-based review[J].Frontline Gastroenterol,2018,9(3):170-174.